BioVisu Accelerates North American Push with 'CANDORLOV' Entry into U.S. Pharmacy Chains and New Product Development

BioVisu is accelerating its entry into the North American market by expanding the offline distribution network of its medical cosmetics brand 'CANDORLOV (CDL)' in the United States and developing new products tailored to local preferences.

On July 14, BioVisu announced that it is pursuing entry into local pharmacy chains to increase sales of the CANDORLOV brand in the United States, while also developing a new sunscreen product specifically for the American market.

The company recently began supplying its products to the U.S. pharmacy chain REALO DRUGS as part of its product development and sales strategy tailored to North American consumers. REALO DRUGS is a pharmacy chain that primarily operates in North Carolina, offering not only prescription and over-the-counter medicines but also medical cosmetic products.

Building on this momentum, BioVisu is in talks to introduce CANDORLOV products at pharmacy chains with approximately 1,400 offline stores across the United States, aiming to further expand its local distribution network.

Simultaneous efforts are underway to develop new products. The company is working on a sunscreen designed exclusively for the U.S. market. Since sunscreen is classified as a general over-the-counter (OTC) drug in the U.S.—in contrast to its classification as a cosmetic in Korea—BioVisu is developing products that comply with U.S. OTC registration standards.

According to the company, market research firm Global Market Insights projects that the North American sun care market will grow from USD 6.6 billion in 2026 to USD 11.2 billion in 2035, representing an average annual growth rate of 6%. BioVisu expects that entering the high-growth North American sun care market will open the door to additional revenue growth.

CANDORLOV is a medical cosmetic brand specializing in a range of basic skincare products, including mask packs, serums, ampoules, toner pads, mists, and creams, highlighting skin regeneration as its key strength.

In the first quarter of this year, Korea’s export statistics for cosmetics showed that exports of basic skincare products to the United States reached USD 470 million, significantly outpacing the USD 60 million for color cosmetics. The company is expanding its local business by focusing on product lines centered on basic skincare products, which are in high demand in the North American market.

BioVisu’s strategy is to strengthen its presence in the North American market by expanding offline distribution channels, in addition to continuing online sales centering on its U.S. subsidiary, 'BioVisu USA.'

A company representative stated, “With offline sales being added to our previously online-focused revenue structure in North America starting this year, we expect to see significantly higher growth than last year.”

BioVisu plans to further solidify its growth foundation in the North American cosmetics market through the expansion of its offline distribution network in the United States and development of locally tailored sun care products.

This content was produced with the assistance of AI translation services.